Igc Pharma Inc (IGC) Gross Profit Margin starting from the second quarter 2026 to second quarter 2025, Profitability Trends and Ranking, Fundamental Ratios - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• Gross Margin
• EBITDA Margin
• Operating Margin
• Net Margin
• Pre-Tax Margin
• Effective Tax Rate
• Free Cash Flow Margin
• Cash Flow Margin
Igc Pharma Inc   (NYSEAMER: IGC)


Igc Pharma Inc 's Gross Profit Margin by quarter

Trends, Rankings, Statistics


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

IGC Gross Profit Margin (Jun 30 2026)
Q2 		(Mar 31 2026)
Q1 		(Sep 30 2025)
Q2 		(Jun 30 2025)
Q1 		(Mar 31 2025)
Q4
Y / Y Revenue Change -19.7 %
Seq. Revenue Change -16.4 %
Revenue In Millions $0.27
Gross Profit Margin 18.11 %
Gross Profit Margin Total Ranking # 3001
Gross Profit In Millions $0.05
Y / Y Gross Profit Change -68.83 %
Seq. Gross Profit Change -12.73 %


Commenting Second Quarter 2026 Gross Profit Margin
Igc Pharma Inc increased Gross Profit Margin through reduction in Cost of Sales and despite contraction in Gross Profit by -12.73 % and Revenue by -16.4 %. Gross Profit Margin in Q2 was 18.11 %, below company average.


Observing second quarter 2026 results within Major Pharmaceutical Preparations industry 135 other companies have achieved higher Gross Profit Margin. While Gross Profit Margin overall ranking has deteriorated relative to the three months before, from to 3001.
Learn about Gross Margin
IGC's Gross Profit Margin second quarter 2026 Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 136
Healthcare Sector # 420
Overall # 2978

Gross Profit Margin Statistics
High Average Low
87 % 30.49 % 1.54 %
(Jun 30 2017)   (Sep 30 2019)


IGC Gross Income Trends • More of IGC's Profitabilty Ratios • IGC Stock Quotes and Charts


Other Gross Profit Margin Profitability Ratios
IGC's Cumulative Gross Profit Margin
Major Pharmaceutical Preparations Industry Gross Profit Margin Trends and Statistics
Healthcare Sector Gross Profit Margin Statistics
Gross Profit Margin Profitability Trends for overall market
IGC's Gross Profit Margin Profitability versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Gross Profit Margin
Lowest Ranking Gross Profit Margin
Gross Profit Margin Profit Margin for IGC's Competitors
Gross Profit Margin Profit Margin for Igc Pharma Inc 's Suppliers
Gross Profit Margin Profit Margin for IGC's Customers

You may also want to know
IGC's Annual Growth Rates IGC's Profitability Ratios IGC's Asset Turnover Ratio IGC's Dividend Growth
IGC's Roe IGC's Valuation Ratios IGC's Financial Strength Ratios IGC's Gross Profit Growth
IGC's Roa IGC's Inventory Turnover Ratio IGC's Growth Rates IGC's Dividend Comparisons


Companies with similar Gross Profit Margin in the quarter ending Jun 30 2026, within Major Pharmaceutical Preparations Industry Gross Profit MarginJun 30 2026 MRQ Gross ProfitJun 30 2026 MRQ Revenue
Bullfrog Ai Holdings Inc   49.63 %$ 0.107  Millions$ 0.215  Millions
Opko Health Inc   48.92 %$ 80.017  Millions$ 163.580  Millions
Cv Sciences Inc   48.58 %$ 1.450  Millions$ 2.985  Millions
Cryoport inc   46.61 %$ 22.824  Millions$ 48.971  Millions
Bausch Health Companies Inc   45.86 %$ 1,308.000  Millions$ 2,852.000  Millions
Amneal Pharmaceuticals Inc   42.01 %$ 334.508  Millions$ 796.197  Millions
Collegium Pharmaceutical Inc   41.86 %$ 83.659  Millions$ 199.878  Millions
Elite Pharmaceuticals Inc   41.75 %$ 13.508  Millions$ 32.355  Millions
Maravai Lifesciences Holdings Inc   40.14 %$ 20.650  Millions$ 51.442  Millions
Viatris Inc   38.77 %$ 1,456.500  Millions$ 3,756.800  Millions
Nrx Pharmaceuticals Inc   38.69 %$ 0.426  Millions$ 1.101  Millions
Amarin Corp Plcuk  35.30 %$ 14.989  Millions$ 42.460  Millions
Phibro Animal Health Corporation  33.88 %$ 134.401  Millions$ 396.747  Millions
Perrigo Company Plc  30.69 %$ 313.900  Millions$ 1,022.800  Millions
60 Degrees Pharmaceuticals Inc   27.32 %$ 0.057  Millions$ 0.208  Millions
Sunshine Biopharma Inc   26.20 %$ 2.427  Millions$ 9.264  Millions
Blue Water Vaccines Inc  25.13 %$ 0.004  Millions$ 0.017  Millions
Newamsterdam Pharma Company N v   24.86 %$ 0.920  Millions$ 3.701  Millions
Prophase Labs Inc   22.35 %$ 0.226  Millions$ 1.011  Millions
Pmgc Holdings Inc   21.01 %$ 0.274  Millions$ 1.307  Millions
Aspire Biopharma Holdings Inc   19.47 %$ 0.012  Millions$ 0.063  Millions
Rockwell Medical inc   18.24 %$ 3.243  Millions$ 17.780  Millions
Igc Pharma Inc   18.11 %$ 0.048  Millions$ 0.265  Millions
Jaguar Health Inc   15.84 %$ 0.194  Millions$ 1.225  Millions
Hcw Biologics Inc   10.82 %$ 0.028  Millions$ 0.257  Millions
China Pharma Holdings Inc  8.81 %$ 0.084  Millions$ 0.948  Millions
Lftd Partners Inc   7.48 %$ 0.651  Millions$ 8.705  Millions
Biora Therapeutics Inc   6.27 %$ 0.202  Millions$ 3.215  Millions




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.